Regeneron/Sanofi's Libtayo OK'd in Europe for lung cancer with ≥50% PD-L1 expression
June 25 2021 - 1:45AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2024 to May 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From May 2023 to May 2024